The effects of cysplatin on human adipose tissue derived mesenchymal stromal cells under different oxygen levels

Cover Page

Abstract


Objective: To evaluate the damaging effects of cisplatin on MMSCs from adipose tissue in a phase of active proliferation and the state of the monolayer, which was exposed at standard (20%) and reduced to 1% and 5% level of oxygen.

Methods: The incubation MMSC with cisplatin was performed on cultures of 2 passage in a state in monolayer and cultures in the active growth phase. Profile surface markers of MMSC determined by flow cytometry. MMSCs viability after incubation with cisplatin was detected by the number of apoptotic and necrotic cells using ANNEXIN V-FITC - PI Kit (Immunotech, France). Standard culture conditions (~ 20% O2) created in a CO2 incubator (Sanyo, Japan), 5% O2 created using multigas incubator (Sanyo, Japan), 1% O2 - using an airtight chamber (Stemcell Technologies, USA).

Results: Incubation of monolayer MMSC with cisplatin at a concentration of 10 ug/ml for 72 hours leads to death of half of the cells in culture under 20% O2, 5% O2 and 1% O2. Cisplatin increased the fracture of PI+-cell, and PI+/Ann+-cells under all culture conditions. The short-term exposure with cisplatin (24 and 48 hours) did not cause the damaging effect. Effects of cisplatin on the MMSC in the growth phase for 48 hours led to accumulation of Ann+-cells and PI+/Ann +-cells under all culture conditions. However least damaging effect of cisplatin was observed in culture under hypoxic conditions (1% O2).

Conclusion: These data suggest that monolayer MMSCs are dying primarily through necrosis, whereas MMSC in the growth phase in response to cisplatin treatment are dying by apoptosis, regardless the oxygen tension.


Yu. V. Rylova

Institute of Biomedical Problems, Russian Academy of Sciences, Moscow

Author for correspondence.
Email: yuliaril@mail.ru

Russian Federation PhD in Biology

L. B. Buravkova

Institute of Biomedical Problems, Russian Academy of Sciences, Moscow;
Lomonosov Moscow State University

Email: buravkova@imbp.ru
MD, PhD, Professor, Corresponding Member of RAS, Deputy Director

B. D. Zhivotovky

Lomonosov Moscow State University;
Institute of Environmental Medicine, Karolinska Institutet, Stockholm

Email: Boris.Zhivotovsky@ki.se
PhD in Biology, Professor, Head of Laboratory

  1. Harvey RL, Chopp M. The therapeutic effects of cellular therapy for functional recovery after brain injury. Phys Med Rehabil Clin N Am. 2003;14(1):143–151. doi: 10.1016/s1047-9651(02)00058-x.
  2. Horwitz EM, Gordon PL, Koo WK, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA. 2002;99(13):8932–8937. doi: 10.1073/pnas.132252399.
  3. Stamm C, Kleine HD, Westphal B, et al. CABG and bone marrow stem cell transplantation after myocardial infarction. Thorac Cardiovasc Surg. 2004;52(3):152–158. doi: 10.1055/s-2004-817981.
  4. Seifrtova M, Havelek R, Cmielova J, et al. The response of human ectomesenchymal dental pulp stem cells to cisplatin treatment. International Endodontic Journal. 2011;45(5):401–412. doi: 10.1111/j.1365-2591.2011.01990.x.
  5. Momekov G, Ferdinandov D, Bakalova A, et al. In vitro toxicological evaluation of a dinuclear platinum (II) complex with acetate ligands. Arch Toxicol. 2006;80(9):555–560. doi: 10.1007/s00204-006-0078-0.
  6. Shaked Y, Henke E, Roodhart JM, et al. Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents. Cancer Cell. 2008;14(3):263–273. doi: 10.1016/j. ccr.2008.08.001.
  7. Chen MF, Lin CT, Chen WC, et al. The sensitivity of human mesenchymal stem cells to ionizing radiation. Int J Rad Oncol Biol Phys. 2006;66(1):244–253. doi: 10.1016/j.ijrobp.2006.03.062.
  8. Li J, Law HK, Lau YL, et al. Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents. Br J Haematol. 2004;127(3):326–334. doi: 10.1111/j.1365-2141.2004.05200.x.
  9. Mueller LP, Luetzkendorf J, Mueller T, et al. Presence of mesenchymal stem cells in human bone marrow after exposure to chemotherapy: evidence of resistance to apoptosis induction. Stem Cells (Dayton, Ohio). 2006;24(12):2753–2765. doi: 10.1634/stemcells.2006-0108.
  10. Young HE, Steele TA, Bray RA, et al. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec. 2001;264(1):51–62. doi: 10.1002/ar.1128.
  11. Ahn JM, You SJ, Lee YM, et al. Hypoxia inducible factor activation protects the kidney from gentamicin-induced acute injury. PLoS One. 2012;7(11):e48952. doi: 10.1371/journal.pone.0048952.
  12. Zarjou A, Kim J, Traylor AM, et al. Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase–1. Am J Physiol Renal Physiol. 2011;300(1):254–262. doi: 10.1152/AJPRENAL.00594.2010.
  13. Wang WW, Wang W, Jiang Y, et al. Human adipose derived stem cells modified by HIF-1a accelerate the recovery of cisplatin induced acute renal injury in vitro. Biotechnol Lett. 2014;36(3):667−676. doi: 10.1007/s10529-013-1389-x.
  14. Zhou Y, Xu H, Xu W, et al. Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Research & Therapy. 2013;4(2):34. doi: 10.1186/scrt194.
  15. Buravkova LB, Rylova YV, Andreeva ER, et al. Low ATP level is sufficient to maintain the uncommitted state of multipotent mesenchymal stem cells. Biochimica et Biophysica Acta. 2013;1830:4418–25. doi: 10.1016/j.bbagen.2013.05.029.
  16. Fehrer C, Brunauer R, Laschober G, et al. Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell. 2007;6(6):745−757. doi: 1 0.1111/j.1474-9726.2007.00336.x.
  17. Буравкова Л.Б., Гринаковская О.С., Андреева Е.Р., Жамбалова А.П., Козионова М.П. Характеристика мезенхимных стромальных клеток из липоаспирата человека, культивируемых при пониженном содержании кислорода // Цитология. – 2009. – Т. 51. – №1. – С. 5–11. [Buravkova LB, Grinakovskaya OS, Andreeva ER, et al. Characteristics of human lipoaspirate-isolated mesenchymal stromal cells cultivated under lower oxygen tension. Cell tissue biol. 2009;51(1):5–11. (In Russ.)] doi: 10.1134/S1990519X09010039
  18. Хаитов Р.М., Пинегин Б.В., Ярилин А.А. Руководство по клинической иммунологии: диагностика заболеваний иммунной системы: руководство для врачей. – М.: ГЭОТАР-Медиа; 2009. 352 с. [Khaitov RM, Pinegin BV, Yarilin AA. Rukovodstvo po klinicheskoi immunologii: diagnostika zabolevanii immunnoi sistemy: rukovodstvo dlya vrachei. Moscow: GEOTAR-Media; 2009. 352 p. (In Russ.)]
  19. Pober JS, Gimbrone MA Jr, Lapierre LA, et al. Overlapping patterns of activation of human endothelial cells by interleukin–1, tumor necrosis factor, and immune interferon. J Immunol. 1986;137(6):1893–1896.
  20. Liang W, Lu C, Li J, et al. p73α regulates the sensitivity of bone marrow mesenchymal stem cells to DNA damage agents. Toxicology. 2010;270(1):49–56. doi: 10.1016/j.tox.2010.01.011.
  21. Liang W, Xia H, Li J, et al. Human adipose tissue derived mesenchymal stem cells are resistant to several chemotherapeutic agents. Cytotechnology. 2011;63(5):523–530. doi: 10.1007/s10616-011-9374-5.
  22. Greijer AE, van der Wall E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol. 2004;57(10):1009–1014.
  23. Bhang SH, Cho SW, Lim JM. Locally delivered growth factor enhances the angiogenic efficacy of adipose-derived stromal cells transplanted to ischemic limbs. Stem Cells. 2009;27(8):1976–1986. doi: 10.1002/stem.115.
  24. Stubbs SL, Hsiao ST, Peshavariya HM, et al. Hypoxic preconditioning enhances survival of human adipose derived stem cells and conditions endothelial cells in vitro. Stem Cells Dev. 2012;21(11):1887–1896. doi: 10.1089/scd.2011.0289.
  25. Doktorova H, Hrabeta J, Khalil MA, et al. Hypoxia induced chemoresistance in cancer cells: The role of not only HIF-1. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159(2):166−177. doi: 10.5507/bp.2015.025.

Views

Abstract - 48

PDF (Russian) - 10

Cited-By


PlumX

Dimensions



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies